3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
44
Squamous Cell Carcinoma of Head and Neck
22
Head and Neck Neoplasms
21
Rectal Neoplasms
17
Colonic Neoplasms
15
Neoplasm Metastasis
13
Neoplasms
12
Carcinoma, Squamous Cell
10
Carcinoma, Non-Small-Cell Lung
10
Recurrence
5
Pancreatic Neoplasms
5
Esophageal Neoplasms
4
Mouth Neoplasms
3
Lung Neoplasms
3
Laryngeal Neoplasms
3
Laryngeal Diseases
3
Breast Neoplasms
3
Tongue Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Pharyngeal Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms, Squamous Cell
2
Hereditary Sensory and Autonomic Neuropathies
2
Glioma
2
Glioblastoma
2
Colorectal Cancer Metastatic
2
Adenocarcinoma of Lung
2
Adenocarcinoma Of Esophagus
2
Interventions
Hyperthermic Intraperitoneal Chemotherapy
4
Cytoreduction Surgical Procedures
4
Cisplatin
3
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
volociximab
1
vandetanib
1
pembrolizumab
1
pasireotide
1
birinapant
1
alvimopan
1
Therapeutic Irrigation
1
Surgical Procedures, Operative
1
Saline Waters
1
Paclitaxel
1
Indocyanine Green
1
Folfox protocol
1
Docetaxel
1
Chemotherapy, Adjuvant
1
Cetuximab
1
Carboplatin
1
Capecitabine
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Peritoneal Neoplasms
×
Cetuximab
×
Clear all
NCT00766142
2025-08-29
COCHISE
Institut Bergonié
Phase 2
Terminated
18 enrolled
9 charts